AnalystsCatherine NovackCatherine Novack's Stock Forecasts
AnalystsCatherine Novack
Analyst Ranking
Top 29%
#1460 out of 5177 analysts
Average Return
+8.46%
Win Rate
30%7 out of 23
Risk vs Reward
Poor
Good
Catherine Novack's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | +265.71% | $27.27 | $99.73 | 2025-03-24 - 2026-01-16 | Strong Buy |
Regulus Therapeutics IncRGLS | +248.47% | $2.29 | $7.98 | 2024-05-30 - 2025-04-30 | Strong Buy |
Capricor Therapeutics IncCAPR | +142.29% | $10.05 | $24.35 | 2025-06-24 - 2026-01-16 | Strong Buy |
Kezar Life Sciences IncKZR | +93.51% | $53.90 | $104.30 | 2021-07-19 - 2022-07-20 | Strong Buy |
Dyne Therapeutics IncDYN | +66.22% | $10.05 | $16.71 | 2025-06-25 - 2026-01-16 | Strong Buy |
Catherine Novack Analyst Color
Get additional color on Catherine Novack's coverage of popular stocks
Catherine Novack's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Septerna IncSEPN | 1 | Strong Buy | $43.00 | +64.94% | Initiates Coverage On | 25 days ago |
Aardvark Therapeutics IncAARD | 1 | Strong Buy | $33.00 | +114.70% | Initiates Coverage On | 4 months ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $30.00 | +79.59% | Initiates Coverage On | 7 months ago |
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $29.00 | +19.10% | Maintains | 7 months ago |
Femasys IncFEMY | 2 | Strong Buy | $6.00 | +821.66% | Maintains | 8 months ago |
Regulus Therapeutics IncRGLS | 2 | Hold | $7.00 | -14.22% | Downgrades | 9 months ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $45.00 | -54.88% | Initiates Coverage On | 10 months ago |
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $11.00 | +566.67% | Initiates Coverage On | a year ago |
Korro Bio IncKRRO | 1 | Strong Buy | $130.00 | N/A | Initiates Coverage On | a year ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
Dare Bioscience IncDARE | 2 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Rezolute IncRZLT | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Calcimedica IncCALC | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Purple Biotech LtdPPBT | 1 | Strong Buy | $160.00 | N/A | Initiates Coverage On | 2 years ago |
Omega Therapeutics IncOMGAQ | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 3 years ago |
Decibel Therapeutics IncDBTX | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Amryt Pharma PLCAMYT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Kezar Life Sciences IncKZR | 1 | Strong Buy | $140.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.